Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged Medicare beneficiaries.
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Diabetes and hypertension are the leading causes of renal failure. This study investigated racial differences in developing ESRD by participants' diabetes and hypertension status. This longitudinal study included 1,306,825 Medicare beneficiaries who were aged > or =66 yr at the study start and followed up to 10 yr from January 1, 1993, for the development of ESRD or death. During the 10 yr, 0.93 patients per 100 received ESRD treatment. After adjustment for age and gender, among patients with diabetes, black patients were 2.4 to 2.7 times and other races/ethnicities 1.6 to 1.7 times more likely than white patients to develop ESRD. Among hypertensive patients, black patients were 2.5 to 2.9 and others 1.7 to 1.8 times more likely than white patients to develop ESRD. Among patients with neither diabetes nor hypertension, black patients were 3.5 and others 2.0 times more likely. Black men with diabetes were 1.9 to 2.1 and women 2.5 to 3.4 times more likely than their white counterparts to develop ESRD. Hypertensive black men were 2.1 to 2.2 and women 2.8 to 3.6 times more likely to develop ESRD. The same findings were noted in women of other races/ethnicities. Compared with white counterparts, mortality was higher for black patients in all cohorts but lower among patients with ESRD. Although they are leading causes for renal failure, diabetes and hypertension do not cause racial differences in developing ESRD. Minority women especially are at greater risk for ESRD than white women. Further studies are needed to determine whether earlier initiation of dialysis is a factor in higher ESRD incidence among minorities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Black patients have a disproportionately higher burden of cardiovascular and advanced kidney disease.12,13,14,15,16,17,18,19,20”
From Association of race/ethnicity, gender, and socioeconomic status with sodium-glucose cotransporter 2 inhibitor use among patients with diabetes in the US (2021) · cites this paper as [14]
Citations
Cites
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
Coresh, J., Astor, B. C., Greene, T., Eknoyan, G., & Levey, A. S. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50007 · Cited by 2,768
Kuczmarski, R. J. (1994) · JAMA · doi:10.1001/jama.272.3.205 · Cited by 2,362
Logistic Regression Using the SAS System : Theory and Application
Allison, P. D. (1999) · Cited by 2,087
Weiner, D. E., Tighiouart, H., Amin, M. G., Stark, P. C., MacLeod, B., Griffith, J. L., Salem, D. N., Levey, A. S., & Sarnak, M. J. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000123691.46138.e2 · Cited by 1,176 · cited 1×
“(27), analyzing large community-based cohort studies, reported significantly higher mortality in black patients with CKD than in white patients with CKD, further suggesting that survival of patients with CKD cannot explain higher ESRD incidence in black than white patients.”
BackgroundRule, A. D., Larson, T. S., Bergstralh, E. J., Slezak, J. M., Jacobsen, S. J., & Cosio, F. G. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-12-200412210-00009 · Cited by 1,066
Foley, R. N., Murray, A. M., Li, S., Herzog, C. A., McBean, A. M., Eggers, P. W., & Collins, A. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004030203 · Cited by 972
Self-citationMurray, C. J. L., Kulkarni, S. C., Michaud, C., Tomijima, N., Bulzacchelli, M. T., Iandiorio, T. J., & Ezzati, M. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030260 · Cited by 762 · cited 2×
“Racial disparity in mortality and life expectancy in the United States did not change between 1982 and 2001, which cannot be explained by income or basic health care access and utilization factors alone (22).”
BackgroundResultDeaths: preliminary data for 2002.
Kochanek, K. D., & Smith, B. L. (2004) · PubMed · Cited by 700
Poggio, E. D., Wang, X., Greene, T., Van Lente, F., & Hall, P. M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004060447 · Cited by 644
Cited by
Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease
Carrero, J. J., Hecking, M., Chesnaye, N. C., & Jager, K. J. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.181 · Cited by 923
Raising awareness of acute kidney injury: a global perspective of a silent killer
Lewington, A. J. P., Cerdá, J., & Mehta, R. L. (2013) · Kidney International · doi:10.1038/ki.2013.153 · Cited by 791
Hypertension in Sub-Saharan Africa: Cross-Sectional Surveys in Four Rural and Urban Communities
Hendriks, M. E., Wit, F. W. N. M., Roos, M. T. L., Brewster, L. M., Akande, T. M., de Beer, I. H., Mfinanga, S. G., Kahwa, A. M., Gatongi, P., Van Rooy, G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032638 · Cited by 417
“compared to Caucasians for a given blood pressure [47,48,49,50] and the onset of CVD in LMIC countries occurs at an earlier age compared to high income countries [39].”
BackgroundEberly, L. A., Yang, L., Eneanya, N. D., Essien, U., Julien, H., Nathan, A. S., Khatana, S. A. M., Dayoub, E. J., Fanaroff, A. C., Giri, J., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.6139 · Cited by 350
siRNA Targeted to p53 Attenuates Ischemic and Cisplatin-Induced Acute Kidney Injury
Molitoris, B. A., Dagher, P. C., Sandoval, R. M., Campos, S. B., Ashush, H., Fridman, E., Brafman, A., Faerman, A., Atkinson, S. J., Thompson, J. D., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008111204 · Cited by 337
Shen, Y., Cai, R., Sun, J., Dong, X., Huang, R., Tian, S., & Wang, S. (2017) · Endocrine · doi:10.1007/s12020-016-1014-6 · Cited by 230
“Furthermore, no statistical significance was found between prospective and retrospective studies (p= 0.093), between the European and the North American regions (p= 0.176), between the mean age below and above 60 years old (p= 0.151), nor between registration and other methods of DM assessment (p= 0.153).”
BackgroundInfluential. Prediction, progression and outcomes of chronic kidney disease in older adults.
Anderson, S., Halter, J. B., Hazzard, W. R., Himmelfarb, J., Horne, F. M., Kaysen, G. A., Kusek, J. W., Nayfield, S. G., Schmader, K., Tian, Y., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008080860 · Cited by 218
Epidemiology of end-stage kidney disease
Gupta, R., Woo, K., & Yi, J. A. (2021) · Seminars in Vascular Surgery · doi:10.1053/j.semvascsurg.2021.02.010 · Cited by 186
“CKD patients with proteinuria, hypertension, and diabetes, as well as Black and Hispanic CKD patients, all have a 2- to 3fold greater risk of progression to ESKD than patients without these risk factors [9].”
BackgroundInfluence of Sex on the Progression of Chronic Kidney Disease
Neugarten, J., & Golestaneh, L. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.12.024 · Cited by 162
Impact of Activated Vitamin D and Race on Survival among Hemodialysis Patients
Wolf, M., Betancourt, J., Chang, Y., Shah, A., Teng, M., Tamez, H., Gutierrez, O., Camargo, C. A., Melamed, M., Norris, K., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091002 · Cited by 161
Screening for Chronic Kidney Disease: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-8-201210160-00533 · Cited by 155
“African Americans are 3 to 5 times more likely to have end-stage renal disease than white Americans (3, 4).”
BackgroundAging, Diabetes, and the Public Health System in the United States
Caspersen, C. J., Thomas, G. D., Boseman, L. A., Beckles, G. L. A., & Albright, A. L. (2012) · American Journal of Public Health · doi:10.2105/ajph.2011.300616 · Cited by 150
Racial Differences in Mortality Among Those with CKD
Mehrotra, R., Kermah, D., Fried, L. F., Adler, S. G., & Norris, K. C. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007070747 · Cited by 152
Quality-of-Life and Mortality in Hemodialysis Patients: Roles of Race and Nutritional Status
Feroze, U., Noori, N., Kovesdy, C. P., Molnar, M. Z., Martin, D. J., Reina-Patton, A., Benner, D., Bross, R., Norris, K. C., Kopple, J. D., et al. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07690910 · Cited by 169
Koye, D. N., Shaw, J. E., Reid, C. M., Atkins, R. C., Reutens, A. T., & Magliano, D. J. (2017) · Diabetic Medicine · doi:10.1111/dme.13324 · Cited by 140
White/black racial differences in risk of end-stage renal disease and death.
Choi, A. I., Rodriguez, R. A., Bacchetti, P., Bertenthal, D., Hernandez, G. T., & O'Hare, A. M. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.11.021 · Cited by 139
Addressing the global burden of chronic kidney disease through clinical and translational research.
OJO, A. O. (2014) · Europe PMC (PubMed Central) · Cited by 130
Charlson comorbidity score is a strong predictor of mortality in hemodialysis patients
Rattanasompattikul, M., Feroze, U., Molnar, M. Z., Dukkipati, R. B., Kovesdy, C. P., Nissenson, A. R., Norris, K. C., Kopple, J. D., & Kalantar‐Zadeh, K. (2011) · International Urology and Nephrology · doi:10.1007/s11255-011-0085-9 · Cited by 131
Loosman, W. L., Rottier, M. A., Honig, A., & Siegert, C. E. H. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0149-7 · Cited by 134
“Despite the differences in health care systems, lower incidence of ESRD in Europe [16, 17, 19], and differences in patient characteristics between European patients and patients from US, the association between depressive symptoms and adverse clinical outcome seems universally present in patients with CKD.”
BackgroundInfluentialIncidence and Predictors of End Stage Renal Disease among Low-Income Blacks and Whites
Lipworth, L., Mumma, M. T., Cavanaugh, K. L., Edwards, T. L., Ikizler, T. A., E.Tarone, R., McLaughlin, J. K., & Blot, W. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048407 · Cited by 101
“Empirical evidence, however, demonstrates that death rates are higher among blacks than whites at all levels of CKD prior to ESRD [8,10], and rates of ESRD incidence are nearly five times higher than rates of cardiovascular death among blacks with hypertension [17], and thus does not lend support to this explanation.”
BackgroundSwartling, O., Yang, Y., Clase, C. M., Fu, E. L., Hecking, M., Hödlmoser, S., Lagerros, Y. T., Evans, M., & Carrero, J. J. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2022030373 · Cited by 117
“Guidelines emphasize referral to nephrologist care according to the principle of risk stratification,1,19,20 the presence of specific comorbidities and cutpoints in eGFR and albuminuria that are not sex based.1,19,20 Whether systematic differences exist in process indicators has not been systematically addressed, but…”
BackgroundInfluentialGender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical Factors
Giandalia, A., Giuffrida, A. E., Gembillo, G., Cucinotta, D., Squadrito, G., Santoro, D., & Russo, G. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115808 · Cited by 121
“Xue, 2007 [51] USA Prospective Female NR NR Higher risk”
BackgroundDisparities in Electronic Health Record Patient Portal Use in Nephrology Clinics
Jhamb, M., Cavanaugh, K. L., Bian, A., Chen, G., Ikizler, T. A., Unruh, M. L., & Abdel-Kader, K. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01640215 · Cited by 97
Sexual dimorphism in the aging kidney: differences in the nitric oxide system
Baylis, C. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.90 · Cited by 98
“all of which are influenced by genetic and environmental factors”
BackgroundTechnology Insight: biomarker development in acute kidney injury—what can we anticipate?
Molitoris, B. A., Melnikov, V. Y., Okusa, M. D., & Himmelfarb, J. (2008) · Nature Reviews Nephrology · doi:10.1038/ncpneph0723 · Cited by 84
Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease
Gutiérrez, O. M., Isakova, T., Andress, D. L., Levin, A., & Wolf, M. S. (2008) · Kidney International · doi:10.1038/ki.2008.4 · Cited by 79
FGF23 in Chronic Kidney Disease
WAHL, P. W., & Wolf, M. S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0887-1_8 · Cited by 82
Trans-ethnic Fine Mapping Highlights Kidney-Function Genes Linked to Salt Sensitivity
Mahajan, A., Rodan, A. R., Le, T. H., Gaulton, K. J., Haessler, J., Stilp, A. M., Kamatani, Y., Zhu, G., Sofer, T., Puri, S., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.07.012 · Cited by 73
Prevalence of Chronic Kidney Disease in Hypertensive Patients in Ghana
Osafo, C., Mate-Kole, M., Affram, K., & Adu, D. (2011) · Renal Failure · doi:10.3109/0886022x.2011.565140 · Cited by 87
Noori, N., Kovesdy, C. P., Dukkipati, R. B., Feroze, U., Molnar, M. Z., Bross, R., Nissenson, A. R., Kopple, J. D., Norris, K. C., & Kalantar‐Zadeh, K. (2011) · American Journal of Nephrology · doi:10.1159/000323972 · Cited by 79
“The annual death rate for non-Hispanic White dialysis patients is significantly higher than that of African Americans. Similarly, for the healthier dialysis patients on the transplant wait list, the annual mortality rate is also higher for non-Hispanics compared with African Americans [ ,”
BackgroundRacial Differences in the Incidence of Chronic Kidney Disease
Muntner, P., Newsome, B., Kramer, H., Peralta, C. A., Kim, Y., Jacobs, D. R., Kiefe, C. I., & Lewis, C. E. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06450611 · Cited by 69
“In addition, the risk for ESRD is higher for African Americans compared with whites with CKD (25,33).”
Backgroundvan den Beukel, T. O., de Goeij, M. C. M., Dekker, F. W., Siegert, C. E. H., & Halbesma, N. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10761012 · Cited by 63
“To investigate the role of health care differences in the faster progression to ESRD in blacks, several studies have tried to control for it by studying cohorts of patients who are insured in the health care system of the United States, for example by Medicare (13,14) or the Department of Veterans Affairs (2,15).”
BackgroundGrams, M. E., Li, L., Greene, T., Tin, A., Sang, Y., Kao, W. H. L., Lipkowitz, M. S., Wright, J. T., Chang, A. R., Astor, B. C., et al. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.07.026 · Cited by 60
Hypertensive Target Organ Damage in Ghanaian Civil Servants with Hypertension
Addo, J., Smeeth, L. L., & Leon, D. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006672 · Cited by 60
“[11,12] In addition, people of black African origin have been identified as having a higher risk of target organ damage compared to white people for a given blood pressure.[13,14,15] Almost all published studies on hypertensive target organ damage from sub Saharan Africa have been hospital-based, potentially capturing…”
BackgroundEpidemiology and causes of chronic kidney disease
Evans, P. D., & Taal, M. W. (2011) · Medicine · doi:10.1016/j.mpmed.2011.04.007 · Cited by 61
Newell, K. A., Formica, R. N., Gill, J. S., Schold, J. D., Allan, J. S., Covington, S., Wiseman, A. C., & Chandraker, A. K. (2016) · American Journal of Transplantation · doi:10.1111/ajt.14173 · Cited by 56
“The goals for the conference were to (1) review and summarize the literature relevant to APOL1 variants and their impact on kidney disease and transplantation, (2) identify knowledge gaps and studies to address existing gaps, and (3) consider how the existing knowledge about APOL1 variants could be integrated into cli…”
BackgroundSuthanthiran, M., Gerber, L. M., Schwartz, J. E., Sharma, V. K., Medeiros-Domingo, M., Marion, R., Pickering, T. G., & August, P. (2009) · Kidney International · doi:10.1038/ki.2009.66 · Cited by 58
“In this regard, we note that racial and ethnic differences exist in the development of ESRD in the USA.(15,16) With respect to the validity of self-identified race/ ethnicity, Tang et al.”
BackgroundEpigenome-wide association study of kidney function identifies trans-ethnic and ethnic-specific loci
Breeze, C. E., Batorsky, A., Lee, M. K., Szeto, M. D., Xu, X., McCartney, D. L., Jiang, R., Patki, A., Kramer, H., Eales, J., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00877-z · Cited by 55
Babayev, R., Whaley‐Connell, A. T., Kshirsagar, A. V., Klemmer, P. J., Navaneethan, S. D., Chen, S., Li, S., McCullough, P. A., Bakris, G. L., & Bomback, A. S. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.11.038 · Cited by 55
A systematic review of ethnic differences in the rate of renal progression in CKD patients
Barbour, S. J., Schachter, M., Er, L., Djurdjev, O., & Levin, A. S. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq283 · Cited by 50
“Several of the studies did not measure baseline socioeconomic or health care access variables [21,23].”
BackgroundBaylis, C. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls171 · Cited by 50
“The female kidney is relatively protected (9,11), and this sex difference is seen across species and persists irrespective of genetic background/race (2,7,9).”
BackgroundOutcomes Associated with Race in Males with Nondialysis-Dependent Chronic Kidney Disease
Kovesdy, C. P., Anderson, J. E., Derose, S. F., & Kalantar‐Zadeh, K. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06031108 · Cited by 40
Race, Genomics and Chronic Disease: What Patients with African Ancestry Have to Say
Horowitz, C. R., Ferryman, K., Negron, R., Sabin, T., Rodriguez, M., Zinberg, R. F., Böttinger, E., & Robinson, M. (2017) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.2017.0020 · Cited by 38
“Major themes emerged: (1) Empowerment: Knowledge of genetic risk will motivate action, not inspire fatalism or decision regret; (2) Accountability: Risk assessment and information can motivate clinicians to focus on better care; (3) Promise: Genetic testing for people of African ancestry holds more promise than peril;…”
Epidemiology and causes of chronic kidney disease
Evans, P. D., & Taal, M. W. (2015) · Medicine · doi:10.1016/j.mpmed.2015.05.005 · Cited by 39
Progress in the development of animal models of acute kidney injury and its impact on drug discovery
Sanz, A. B., Sánchez-Niño, M. D., Martín-Cleary, C., Ortíz, A., & Ramos, A. M. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.793667 · Cited by 40
“However, even when not needing RRT, AKI is still a serious disorder, conferring an increased risk of death that persists for over a year following the AKI episode and also increasing the risk of chronic kidney disease (CKD) progression [2-5].”
BackgroundQi, A. C., Butler, A. M., & Maddox, K. E. J. (2019) · Health Affairs · doi:10.1377/hlthaff.2018.05406 · Cited by 36
Goncalves, G. M. R., & da Silva, E. N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203992 · Cited by 38
Sobamowo, H., & Prabhakar, S. S. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.018 · Cited by 34
Effect of blood pressure on the retinal vasculature in a multi-ethnic Asian population
Jeganathan, V. S. E., Sabanayagam, C., Tai, E. S., Lee, J., Sun, C., Kawasaki, R., Nagarajan, S., Huey-Shi, M. H., Sandar, M., & Wong, T. Y. (2009) · Hypertension Research · doi:10.1038/hr.2009.130 · Cited by 34
Kalaitzidis, R., Li, S., Wang, C., Chen, S., McCullough, P. A., & Bakris, G. L. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.11.028 · Cited by 39
“The Kidney Early Evaluation Program (KEEP), a National Kidney Foundation screening program to help promote CKD awareness, targets individuals 18 years or older with diabetes or hypertension or otherwise at high risk of CKD.”
ResultInfluentialCardiovascular disease in chronic kidney disease
Saran, A. M., & DuBose, T. D. (2008) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944708096379 · Cited by 38
“African Americans have a 3.5-fold higher risk of progressing to ESKD than Caucasians.”
BackgroundInfluentialAdiposity Patterns and the Risk for ESRD in Postmenopausal Women
Franceschini, N., Gouskova, N., Reiner, A. P., Bostom, A. G., Howard, B. V., Pettinger, M. B., Umans, J. G., Brookhart, M. A., Winkelmayer, W. C., Eaton, C. B., et al. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02860314 · Cited by 38
“5% of the adult United States population, with a high burden occurring among aging individuals and racial/ethnic minorities (4), including blacks (5) and Hispanics (6).”
BackgroundBock, F. M., Stewart, T. G., Robinson‐Cohen, C., Morse, J. L., Kabagambe, E. K., Cavanaugh, K. L., Birdwell, K. A., Hung, A. M., Abdel-Kader, K. F. M., Siew, E. D., et al. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1502-z · Cited by 33
“demonstrated that these do not fully explain the racial disparity in ESRD risk [8].”
BackgroundSexual Dimorphism of the Aging Kidney: Role of Nitric Oxide Deficiency
Baylis, C. (2008) · Physiology · doi:10.1152/physiol.00001.2008 · Cited by 34
Lab-based and diagnosis-based chronic kidney disease recognition and staging concordance
Diamantidis, C. J., Hale, S. L., Wang, V., Smith, V. A., Scholle, S. H., & Maciejewski, M. L. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1551-3 · Cited by 33
Retinal vascular fractal and blood pressure in a multiethnic population
Sng, C. C. A., Wong, W. L., Cheung, C. Y.-L., Lee, J., Tai, E. S., & Wong, T. Y. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e328362c201 · Cited by 29
“In contrast, other indicators of hypertensive end-organ damage differ between racial groups, including renal disease [37], coronary artery disease [38], left ventricular hypertrophy [39] and cerebrovascular disease [40].”
BackgroundSmoking and Risk of Kidney Failure in the Singapore Chinese Health Study
Jin, A., Koh, W., Chow, K. Y., Yuan, J., & Jafar, T. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062962 · Cited by 31
“[24–27] Nevertheless, the reduction in risk of kidney failure with smoking cessation is highly suggestive of an independent predictive and causal nature of the association.”
BackgroundEnd-stage renal disease in patients with rheumatoid arthritis
Paudyal, S., Yang, F. M., Rice, C., Chen, C.-C., Skelton, M., Bethel, M., Brown, S., Nahman, N. S., & Carbone, L. D. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.07.016 · Cited by 28
“consistent with the general population of patients with ESRD who have hypertension as the etiology of their ESRD (12, 13).”
BackgroundInfluence of Recipient Race on the Outcome of Simultaneous Pancreas and Kidney Transplantation
Luan, F. L., Kommareddi, M., Cibrik, D. M., Samaniego, M., & OJO, A. O. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03211.x · Cited by 24
“The racial disparity in the outcome of chronic kidney disease in general, and of kidney transplantation in particular has been widely documented over the past 20 years (15,23,33).”
BackgroundReappraisal of the Impact of Race on Survival in Patients on Dialysis
Buckalew, V. M., & Freedman, B. I. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.10.062 · Cited by 25
Lessons from CKD-Related Genetic Association Studies–Moving Forward
Limou, S., Vince, N., & Parsa, A. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09030817 · Cited by 23
Jung, C., Heo, G. Y., Park, J. T., Joo, Y. S., Kim, H. W., Lim, H., Chang, T. I., Kang, E. W., Yoo, T., Kang, S., et al. (2021) · Clinical Research in Cardiology · doi:10.1007/s00392-021-01872-5 · Cited by 23
“In fact, there is evidence that women are less aware of CKD [45], less educated [46], more socioeconomically deprived [47], and have less access to health care than men [48].”
BackgroundRacial Differences in Mortality and ESRD
Norris, K. C., Mehrotra, R., & Nissenson, A. R. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.06.004 · Cited by 21
Udayaraj, U. P., Ben‐Shlomo, Y., Roderick, P., Casula, A., Ansell, D., Tomson, C., & Caskey, F. J. (2009) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2009.093518 · Cited by 23
ESRD among Immigrants to Ontario, Canada: A Population-Based Study
Perl, J. M., McArthur, E., Tan, V. S., Nash, D. M., Garg, A. X., Harel, Z., Li, A. H., Sood, M. M., Ray, J. G., & Wald, R. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017101055 · Cited by 20
Hughes, O., Bentley, A. R., Breeze, C. E., Aguet, F., Xu, X., Nadkarni, G. N., Sun, Q., Lin, B. M., Gilliland, T., Meyer, M., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100468 · Cited by 21
Vitamin D and Racial Disparity in Albuminuria: NHANES 2001-2006
Fiscella, K. A., Winters, P., & Ogedegbe, G. G. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.108 · Cited by 19
Arora, P., Rajagopalan, S., Patel, N., Nainani, N., Venuto, R. C., & Lohr, J. W. (2012) · BMC Nephrology · doi:10.1186/1471-2369-13-4 · Cited by 19
“Several factors which have been proposed to explain this [3,4,14,18-29].”
BackgroundDay, E. C., Li, Y., Roux, A. V. D., Kandula, N. R., Moran, A. E., Rosas, S. E., Shlipak, M. G., & Peralta, C. A. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq676 · Cited by 18
“3-fold higher incidence compared with non-Hispanic whites in the USA [23,34,49,50].”
BackgroundMelancon, J. K., Kucirka, L. M., Boulware, L. E., Powe, N. R., Locke, J. E., Montgomery, R. A., & Segev, D. L. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02845.x · Cited by 17
“Our analysis of national data shows evidence that the former was accomplished, but not the latter, suggesting that the underlying mechanism for ethnic/racial disparities in access to SPKT is not differential insurance coverage as previously hypothesized (16,19).”
Sexual Dimorphism, the Aging Kidney, and Involvement of Nitric Oxide Deficiency
Baylis, C. (2009) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2009.07.003 · Cited by 17
Adaptation to Nephron Loss and Mechanisms of Progression in Chronic Kidney Disease
Taal, M. W., & Brenner, B. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10051-x · Cited by 18
Yang, J. W., Hutchinson, I. V., Shah, T., Fang, J., & Min, D. I. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0376-8 · Cited by 15
“There appear to be clear individual differences as well as ethnic differences in the susceptibility of certain people to renal dysfunction due to hypertensive nephropathy [13].”
BackgroundLin, M., Chiu, Y., Hsu, Y., Wu, M.-S., Chang, J., Hsu, C., Yang, C., Yang, W., & Hwang, S. (2022) · Kidney Medicine · doi:10.1016/j.xkme.2022.100485 · Cited by 14
Incidence of End Stage Renal Disease among Type 1 Diabetes
Lin, W., Li, C., Wang, W.-M., Yang, D., Kuo, T.-H., & Wang, M.-C. (2014) · Medicine · doi:10.1097/md.0000000000000274 · Cited by 14
“It is well-known that African-American and Asian (Taiwanese and Japanese) people have a greater risk for developing ESRD, when compared to Caucasians, in all cohorts.(9,13) Asians constitute a large portion of non-Black groups in the U.”
BackgroundEnd stage renal disease in French Guiana (data from R.E.I.N registry): South American or French?
Rochemont, D. R., Meddeb, M., Roura, R., Couchoud, C., Nacher, M., & Basurko, C. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0614-6 · Cited by 14
“Several studies have also shown that afro-caribbean and indo-asian ancestry were associated with a greater prevalence of diabetes mellitus and thus was associated with a greater risk of chronic renal failure [22 – 24].”
Patrice, H. M., Kengne, A. P., François, K. F., Djantio, H., Solange, D. M., Gloria, A. E., & Choukem, S. P. (2020) · BMC Nephrology · doi:10.1186/s12882-020-01760-6 · Cited by 25
“But this progression varies across populations and according to the presence of certain comorbidities [42, 43, 45, 46].”
BackgroundSheer, R. L., Nair, R., Pasquale, M. K., Evers, T., Cockrell, M. M., Gay, A., Singh, R., & Schmedt, N. (2022) · Journal of Primary Care & Community Health · doi:10.1177/21501319211063726 · Cited by 22
Target organ damage among hypertensive adults in rural Nigeria
Nelissen, H. E., Hendriks, M. E., Wit, F. W. N. M., Bolarinwa, O. A., Osagbemi, G. K., Bindraban, N. R., Lange, J. M. A., Akande, T. M., Schultsz, C., & Brewster, L. M. (2013) · Journal of Hypertension · doi:10.1097/hjh.0000000000000056 · Cited by 13
“In addition, people of African descent have a higher risk of developing target organ damage (TOD) than whites for any given blood pressure [5,6].”
BackgroundSaeed, F., Ladwig, S., Allen, R. J., Eneanya, N. D., Tamura, M. K., & Fiscella, K. A. (2022) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2022.12.002 · Cited by 13
Snow, K., Patzer, R. E., Patel, S. A., & Harding, J. L. (2022) · Kidney360 · doi:10.34067/kid.0007872021 · Cited by 12
“This is in contrast to studies of ESKD incidence, in which regions with a higher proportion of Black residents had higher ESKD incidence (10), and several individual-level studies that demonstrate Black (versus White) people are more likely to develop ESKD and at a faster rate (27).”
ResultLi, P., Zhang, P., Guan, D., Guo, J. S., Zhang, Y., Pavkov, M. E., Bullard, K. M., & Shao, H. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14894 · Cited by 11
“Racial and ethnic minorities with diabetes also have worse outcomes, including higher rates of severe hypoglycaemia, amputations, endstage kidney disease and death.(2,3) Besides genetic and biological factors,(4) diabetes management and quality of care play important roles in racial and ethnic disparities in diabetes…”
BackgroundJacob, A. N., Khuder, S., Malhotra, N., Sodeman, T. C., Gold, J. P., Malhotra, D. K., & Shapiro, J. I. (2010) · Nephron Clinical Practice · doi:10.1159/000315884 · Cited by 9
Higher Incidence of ESRD than Mortality in the AASK Study
Fried, L. F. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010060623 · Cited by 9
Racial Disparities in Heart Transplantation: Long‐Term Graft Survival and Nonmortality Outcomes
Hamilton, S., Wayda, B. J., Weng, Y., Zhang, S., & Khush, K. K. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.038892 · Cited by 7
Yan, G., Nee, R., Scialla, J. J., Greene, T., Yu, W., Heng, F., Cheung, A. K., & Norris, K. C. (2024) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000300 · Cited by 9
New renal drug development to face chronic renal disease
Moll, S., Meier, M., Formentini, I., Pomposiello, S. I., & Prunotto, M. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.956075 · Cited by 7
“However, it is clear that CKD patients are a heterogeneous group, with different diagnoses, etiologies and prognoses [83-85].”
BackgroundRacial differences in parathyroid hormone levels in CKD
Isakova, T. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs173 · Cited by 8
“Blacks with CKD are at greater risk for cardiovascular disease and end-stage renal disease compared with whites [17, 18].”
BackgroundRacial Differences in Survival of Incident Home Hemodialysis and Kidney Transplant Patients
Molnar, M. Z., Ravel, V., Streja, E., Kovesdy, C. P., Mehrotra, R., & Kalantar‐Zadeh, K. (2015) · Transplantation · doi:10.1097/tp.0000000000001005 · Cited by 6
“First, African Americans compared with whites have a higher probability of developing ESRD, secondary to genetic predisposition even in strata of patients with a history of diabetes and hypertension.(38) In addition, the patient and renal allograft survival is significantly lower in African Americans than that in whit…”
BackgroundRacial minority groups on dialysis in Europe: a literature review.
van den Beukel, T. O., Jager, K. J., Siegert, C. E. H., Schoones, J. W., & Dekker, F. W. (2010) · PubMed · Cited by 6
The structural conundrum of parolees and kidney transplantation
Ahmad, M. U., & Eves, M. M. (2020) · Clinical Transplantation · doi:10.1111/ctr.14104 · Cited by 6
An overview of diversity, equity, and inclusion in the United States transplant surgery workforce
Muñoz, N., Obayemi, J. E., Chan, N. W., & McElroy, L. M. (2025) · Current Problems in Surgery · doi:10.1016/j.cpsurg.2025.101732 · Cited by 6
“5,6,40,41 Evidence suggests that the transplant evaluation process is susceptible to subjectivity and bias.”
Increased Incidence of Chronic Kidney Injury in African Americans Following Cardiac Transplantation
Bayne, J., Francke, M., Ma, E., Rubin, G. A., Avula, U. M. R., Baksh, H., Givens, R. C., & Wan, E. Y. (2020) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-020-00906-4 · Cited by 5
Left ventricular hypertrophy in hypertensive type 2 diabetic patients according to renal function
Blanchet‐Deverly, A., Kangambega, P., Hue, K., Donnet, J.-P., Merault, H., & Foucan, L. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.12.004 · Cited by 6
Maione, A., & Strippoli, G. F. (2009) · PubMed · Cited by 4
Abd, M., Abdallah, F., Baki, A. H., Hakim, S. A., & Kamel, C. R. (2014) · Cited by 4
Akwo, E. A., Cavanaugh, K. L., Ikizler, T. A., Blot, W. J., & Lipworth, L. P. (2015) · BMC Nutrition · doi:10.1186/s40795-015-0022-x · Cited by 3
Changing patterns of renal replacement therapy
Ansell, D., Risdale, S., & Caskey, F. J. (2010) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199560035.003.0002 · Cited by 3
Gender Issues in Chronic Kidney Disease
Neugarten, J., & Reckelhoff, J. F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815876-0.00007-3 · Cited by 3
Rashdi, F. A., Tabche, C., Atwan, Z., Al-Qanubi, H., Khaldi, S. A., Al-Zadjali, N., & Rawaf, S. (2026) · Frontiers in Nephrology · doi:10.3389/fneph.2026.1735217 · Cited by 2
Metadata
- Authors
- Xue, J. L., Eggers, P. W., Agodoa, L. Y., Foley, R. N., & Collins, A. J.
- Affiliations
- University of Minnesota (US)
- National Institutes of Health (US)
- Corresponding author
- Xue, Jay L.
- Foley, Robert N.
- Collins, Allan J.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2007-04
- Volume
- 18
- Issue
- 4
- Pages
- 1299-1306
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2027108122
- Cited by
- 117
- References
- 39
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 8 · 2021: 7 · 2020: 4 · 2019: 8 · 2018: 3 · 2017: 5 · 2016: 5 · 2015: 5 · 2014: 8 · 2013: 6 · 2012: 11
- FWCI
- 7.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (N01-DK-9-2343)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Social Sciences › Health › Health disparities and outcomes
- Keywords
- end-stage renal disease, racial disparities, ethnic differences, diabetes mellitus, hypertension, Medicare beneficiaries, older adults, Black patients, minority women, mortality, dialysis initiation, renal failure
- MeSH terms
- Aged, Aged, 80 and over, Female, Medicare, Humans, Kidney Failure, Chronic, Longitudinal Studies, Male, Black People, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.